Abstract
Objectives We aimed to describe the procedural characteristics and 5-year outcome of consecutive patients undergoing unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) at our tertiary care centre between 1 January 2007 and 31 December 2008.Methods and results 76 patients underwent ULMCA PCI during the study period. Drug-eluting stents were used in 61. The mean EuroSCORE II, additive and logistic EuroSCOREs and SYNTAX score were 14.81, 10.2, 25.25 and 27.3, respectively. 30-day and 5-year mortality were 14.5% and 50%, respectively, with early mortality related exclusively to circulatory causes and late mortality being non-cardiac in 74%. Clinical presentation was a key determinant of 5-year mortality. During follow-up 1 patient suffered a non-fatal myocardial infarction (MI) related to ULMCA in-stent restenosis (ISR), 2 others suffered MI related to non-ULMCA lesions. Definite and probable stent thrombosis occurred in 1 (non-ULMCA stent) and 1, respectively. 3 patients had ULMCA ISR, 14 had non-ULMCA ISR necessitating redo revascularisation.Conclusions ULMCA PCI is a good treatment modality in patients who cannot undergo CABG. Clinical presentation and downstream disease have a major influence on the 5-year outcome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
